Lung Cancer News and Research

Latest Lung Cancer News and Research

Experimental drug Revlimid showing promise as treatment for myelodysplastic syndrome (MDS)

Alan List, M.D., leader of the Hematologic Malignancies Program at the H. Lee Moffitt Cancer Center & Research Institute, recently conducted a phase I/II trial of the experimental drug Revlimid showing promise as an innovative way to treat patients with myelodysplastic syndrome (MDS), a form of pre-leukemia.

10 Feb 2005

Patients with cancer have a 7-fold increased risk for blood clots in the legs or lungs

Studies that identify patients at highest risk of thrombosis are scarce, according to background information in the article. It is unclear what risks are for various types and stages of cancer.

9 Feb 2005

Smoke free laws protect health and save lives worldwide

In a report out today (8 February 2005) from the BMA's Tobacco Control Resource Centre (TCRC), doctors' leaders from eight countries, including Scotland, describe the success of anti-smoking legislation.

7 Feb 2005

Eleventh Edition of the Report on Carcinogens

The Department of Health and Human Services released its Eleventh Edition of the Report on Carcinogens today, adding seventeen substances to the growing list of cancer-causing agents, bringing the total to 246.

31 Jan 2005

Nicotine may hold promise in the early diagnosis of Alzheimer's disease

The chemical nicotine--a main ingredient in tobacco--may hold promise in the early diagnosis of Alzheimer's disease, give insight into therapeutic interventions for nicotine addiction and possibly complement the diagnosis of certain forms of lung cancer, according to a study in the January issue of the Society of Nuclear Medicine's Journal of Nuclear Medicine.

31 Jan 2005

Passive smoking increases likelihood of lung cancer in children later in life

Children who are exposed to environmental tobacco smoke (passive smoking) are at a higher risk of developing lung cancer as adults, says a paper in this week's BMJ.

30 Jan 2005

Why some men develop aggressive prostate cancer that becomes resistant to hormone-withdrawal therapy

Researchers found that certain mutations in a protein called the androgen receptor cause advanced and invasive prostate cancer when put into otherwise healthy mice. The androgen receptor's normal function is to control growth of the prostate gland in response to cues from male hormones called androgens, which have long been thought to stimulate prostate tumors.

26 Jan 2005

Screening tests find colorectal cancer in its earliest stages when it can be treated more successfully

Colorectal cancer (CRC) is second only to lung cancer as the leading cause of cancer-related death in the United States. In 2004, it’s estimated that CRC caused nearly 57,000 deaths.

18 Jan 2005

Scientific evidence on passive smoking is inconclusive

Scientific evidence on environmental tobacco smoke (ETS or so-called "passive smoking") is inconclusive and does not justify a total ban on smoking in public places, it was argued at a conference on public smoking in Edinburgh today.

17 Jan 2005

Avastin available across Europe within the next few weeks

Roche has announced that the European Commission has approved Avastin (bevacizumab, rhuMAb-VEGF), the new innovative anti-angiogenesis drug, for the treatment of patients with previously untreated metastatic colorectal cancer.

16 Jan 2005

Alarming ignorance about cancer in Britain

There is an alarming ignorance about cancer and how to reduce the risk of the disease which is Britain's biggest killer – a special survey reveals today.

13 Jan 2005

Drinking water with high levels of arsenic increases risk of lung cancer

Residents of Taiwan who consumed drinking water with high levels of arsenic have a higher risk of lung cancer, with cigarette smokers from this group having an even greater risk, according to a study in the December 22/29 issue of JAMA.

22 Dec 2004

Relatives of lung cancer patients up to 3.5 times greater risk of developing lung cancer

First-degree relatives of lung cancer patients have a 2 to 3.5 times greater risk of developing lung cancer than the general population, and tobacco smoke plays a major role, even among those with a genetic predisposition, according to a study in the December 22/29 issue of JAMA.

22 Dec 2004

Write to your MPs, BMA tells doctors

BMA Cymru Wales is calling on doctors across Wales to write to their members of parliament to support a ban on smoking in public places.

22 Dec 2004

Gulf War report confirms link between lung cancer and combustion products

The available evidence is too sparse or of insufficient quality to determine whether the majority of health problems that may be experienced by Gulf War veterans could be associated with exposures to fuels for military vehicles, propellents in Scud missiles, or substances given off by combustion sources such as oil-well fires, exhausts, and tent heaters

21 Dec 2004

Radon in homes and risk of lung cancer

Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies, BMJ Online First.

21 Dec 2004

How radiation therapy is used to safely and effectively treat various cancers

To help cancer patients and their families better understand their treatment options before making a decision, the American Society for Therapeutic Radiology and Oncology has published seven patient information brochures that explain how radiation therapy is used to safely and effectively treat various cancers.

16 Dec 2004

False positive cancer screening tests result not only in anxiety but also additional economic costs

Cancer screening tests can frequently produce false positive outcomes that may result not only in anxiety but also additional economic costs as well, according to research conducted by scientists at the Henry Ford Health System, Detroit, Mich., and published in the December issue of Cancer Epidemiology, Biomarkers & Prevention

14 Dec 2004

DNA provides key to successful quitting smoking

Smokers who want to quit now have up to nine times greater chance of doing so, thanks to new DNA testing launched today by Oxford University’s newest spin-out, G-Nostics.

4 Dec 2004

Two out of every three Americans know someone stricken by lung cancer

Two out of every three Americans know someone stricken by lung cancer, yet more than half of Americans don't realize that lung cancer is among the most lethal of cancers, according to a nationwide survey conducted on behalf of The Lung Cancer Online Foundation.

3 Dec 2004